Blood injections after jaw surgery: which works better?

NCT ID NCT07359131

Not yet recruiting Knowledge-focused Sponsor: Jingping Wang, MD, Ph.D. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 700 adults who had jaw joint (TMJ) surgery and received either platelet-rich plasma (PRP) or platelet-rich fibrin (PRF) injections during the operation. Researchers will review medical records to see which group had less pain and better jaw function six months later. The goal is to find out if one injection leads to a smoother recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) injections
What this could lead to: If this study shows one injection works better, it could guide surgeons on which to use for better pain relief and jaw recovery after TMJ surgery.
What could go wrong: This is an observational study that looks back at medical records, not a controlled experiment. It can show links but not prove cause and effect. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TEMPOROMANDIBULAR JOINT DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

temporomandibular joint disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TEMPOROMANDIBULAR JOINT DISORDERS

Contacts and locations

Locations

Meikun Wang

Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.